---
title: "Bayer's Q1 Profit Surpasses Expectations Due to Strong Crop Science Performance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286044370.md"
description: "Bayer, the chemical giant, reported first-quarter profits that exceeded expectations, primarily driven by the robust performance of its Crop Science division. According to Jin10, Bayer announced on Tuesday that its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose to 4.45 billion euros (approximately $5.2 billion). This figure surpassed the widely anticipated 3.9 billion euros. The company confirmed its full-year outlook, adjusted for currency effects."
datetime: "2026-05-12T06:07:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286044370.md)
  - [en](https://longbridge.com/en/news/286044370.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286044370.md)
generator: "portal-rs"
---

# Bayer's Q1 Profit Surpasses Expectations Due to Strong Crop Science Performance

Bayer, the chemical giant, reported first-quarter profits that exceeded expectations, primarily driven by the robust performance of its Crop Science division. According to Jin10, Bayer announced on Tuesday that its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose to 4.45 billion euros (approximately $5.2 billion). This figure surpassed the widely anticipated 3.9 billion euros. The company confirmed its full-year outlook, adjusted for currency effects.

### Related Stocks

- [BAYZF.US](https://longbridge.com/en/quote/BAYZF.US.md)
- [BAYRY.US](https://longbridge.com/en/quote/BAYRY.US.md)
- [BAYN.DE](https://longbridge.com/en/quote/BAYN.DE.md)

## Related News & Research

- [Bayer, Neste sign commercial deal to expand newgold winter rapeseed for biofuels in US Great Plains](https://longbridge.com/en/news/298454887.md)
- [Voyageur Pharma proves Mueller iodine extraction process, hits 99.8% purity in lab tests](https://longbridge.com/en/news/298450415.md)
- [Bayer forms new Ruveon business for Roundup in US after legal win](https://longbridge.com/en/news/291511128.md)
- [BAYN: Q2 2026 delivered solid sales and EBITDA growth, but free cash flow was impacted by litigation](https://longbridge.com/en/news/294773093.md)
- [Key facts: Bayer Q1 EBITDA Up; 65K Roundup Claims; Pharma Sales Hit](https://longbridge.com/en/news/286182548.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**